Literature DB >> 20643144

Relative affinity of calcium pump isoforms for phospholamban quantified by fluorescence resonance energy transfer.

Zhanjia Hou1, Seth L Robia.   

Abstract

To investigate the regulation of SERCA1a [sarco(endo)plasmic reticulum calcium ATPase] and SERCA2a calcium pump isoforms by phospholamban (PLB), we quantified PLB-SERCA interactions by fluorescence resonance energy transfer (FRET) in live cells. For both SERCA1a and SERCA2a, FRET to PLB increased with increasing protein expression level to a maximum value corresponding to a probe separation distance of 64 A. The data indicate that the respective regulatory complexes assume the same overall quaternary conformation. However, FRET measurements also revealed that PLB has a 50% higher apparent affinity for SERCA1a relative to SERCA2a. The results suggest that despite the structural similarities of the respective regulatory complexes, there is preferential binding of PLB to SERCA1a over SERCA2a. This apparent selectivity may have implications for biochemical studies in which SERCA1a is used as a substitute for SERCA2a. It may also be an important strategic consideration for therapeutic overexpression of SERCA isoforms in cardiac muscle. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643144      PMCID: PMC2935190          DOI: 10.1016/j.jmb.2010.07.023

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  23 in total

1.  Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum.

Authors:  Deborah A Ferrington; Qing Yao; Thomas C Squier; Diana J Bigelow
Journal:  Biochemistry       Date:  2002-11-05       Impact factor: 3.162

2.  Photobleaching-corrected FRET efficiency imaging of live cells.

Authors:  Tomasz Zal; Nicholas R J Gascoigne
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

3.  Targeting sarcoplasmic reticulum Ca2+ uptake to improve heart failure: hit or miss.

Authors:  Karin R Sipido; Peter Vangheluwe
Journal:  Circ Res       Date:  2010-02-05       Impact factor: 17.367

4.  Localization of phospholamban in slow but not fast canine skeletal muscle fibers. An immunocytochemical and biochemical study.

Authors:  A O Jorgensen; L R Jones
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

5.  Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban.

Authors:  A G Brittsan; A N Carr; A G Schmidt; E G Kranias
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

6.  Spatial and dynamic interactions between phospholamban and the canine cardiac Ca2+ pump revealed with use of heterobifunctional cross-linking agents.

Authors:  Zhenhui Chen; David L Stokes; William J Rice; Larry R Jones
Journal:  J Biol Chem       Date:  2003-09-12       Impact factor: 5.157

7.  Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses.

Authors:  Leonard Dode; Jens Peter Andersen; Natalie Leslie; Jittima Dhitavat; Bente Vilsen; Alain Hovnanian
Journal:  J Biol Chem       Date:  2003-09-15       Impact factor: 5.157

Review 8.  Phospholamban: a crucial regulator of cardiac contractility.

Authors:  David H MacLennan; Evangelia G Kranias
Journal:  Nat Rev Mol Cell Biol       Date:  2003-07       Impact factor: 94.444

9.  Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.

Authors:  J K Gwathmey; L Copelas; R MacKinnon; F J Schoen; M D Feldman; W Grossman; J P Morgan
Journal:  Circ Res       Date:  1987-07       Impact factor: 17.367

10.  Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase.

Authors:  Chikashi Toyoshima; Michio Asahi; Yuji Sugita; Reena Khanna; Takeo Tsuda; David H MacLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

View more
  16 in total

1.  Phospholamban binds with differential affinity to calcium pump conformers.

Authors:  Philip Bidwell; Daniel J Blackwell; Zhanjia Hou; Aleksey V Zima; Seth L Robia
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

2.  Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase.

Authors:  Sandeep Pallikkuth; Daniel J Blackwell; Zhihong Hu; Zhanjia Hou; Dane T Zieman; Bengt Svensson; David D Thomas; Seth L Robia
Journal:  Biophys J       Date:  2013-10-15       Impact factor: 4.033

3.  Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban.

Authors:  Neha Abrol; Pieter P de Tombe; Seth L Robia
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

4.  Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy.

Authors:  Delaine K Ceholski; Catharine A Trieber; Howard S Young
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

5.  Oligomeric interactions of sarcolipin and the Ca-ATPase.

Authors:  Joseph M Autry; John E Rubin; Sean D Pietrini; Deborah L Winters; Seth L Robia; David D Thomas
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

6.  Newly Discovered Micropeptide Regulators of SERCA Form Oligomers but Bind to the Pump as Monomers.

Authors:  Deo R Singh; Michael P Dalton; Ellen E Cho; Marsha P Pribadi; Taylor J Zak; Jaroslava Šeflová; Catherine A Makarewich; Eric N Olson; Seth L Robia
Journal:  J Mol Biol       Date:  2019-08-23       Impact factor: 5.469

7.  Cardiac Calcium ATPase Dimerization Measured by Cross-Linking and Fluorescence Energy Transfer.

Authors:  Daniel J Blackwell; Taylor J Zak; Seth L Robia
Journal:  Biophys J       Date:  2016-09-20       Impact factor: 4.033

8.  ATP-Binding Cassette Transporter Structure Changes Detected by Intramolecular Fluorescence Energy Transfer for High-Throughput Screening.

Authors:  Surtaj H Iram; Simon J Gruber; Olga N Raguimova; David D Thomas; Seth L Robia
Journal:  Mol Pharmacol       Date:  2015-04-29       Impact factor: 4.436

9.  Phosphomimetic mutations enhance oligomerization of phospholemman and modulate its interaction with the Na/K-ATPase.

Authors:  Qiujing Song; Sandeep Pallikkuth; Julie Bossuyt; Donald M Bers; Seth L Robia
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

10.  Phospholamban C-terminal residues are critical determinants of the structure and function of the calcium ATPase regulatory complex.

Authors:  Neha Abrol; Nikolai Smolin; Gareth Armanious; Delaine K Ceholski; Catharine A Trieber; Howard S Young; Seth L Robia
Journal:  J Biol Chem       Date:  2014-07-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.